These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25477170)

  • 1. VEGFR targeting leads to significantly enhanced tumor uptake of nanographene oxide in vivo.
    Shi S; Yang K; Hong H; Chen F; Valdovinos HF; Goel S; Barnhart TE; Liu Z; Cai W
    Biomaterials; 2015 Jan; 39():39-46. PubMed ID: 25477170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo targeting of metastatic breast cancer via tumor vasculature-specific nano-graphene oxide.
    Yang D; Feng L; Dougherty CA; Luker KE; Chen D; Cauble MA; Banaszak Holl MM; Luker GD; Ross BD; Liu Z; Hong H
    Biomaterials; 2016 Oct; 104():361-71. PubMed ID: 27490486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene.
    Hong H; Yang K; Zhang Y; Engle JW; Feng L; Yang Y; Nayak TR; Goel S; Bean J; Theuer CP; Barnhart TE; Liu Z; Cai W
    ACS Nano; 2012 Mar; 6(3):2361-70. PubMed ID: 22339280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A vascular endothelial growth factor 121 (VEGF(121))-based dual PET/optical probe for in vivo imaging of VEGF receptor expression.
    Kang CM; Koo HJ; Lee KC; Choe YS; Choi JY; Lee KH; Kim BT
    Biomaterials; 2013 Sep; 34(28):6839-45. PubMed ID: 23787114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A tyrosine kinase inhibitor-based high-affinity PET radiopharmaceutical targets vascular endothelial growth factor receptor.
    Li F; Jiang S; Zu Y; Lee DY; Li Z
    J Nucl Med; 2014 Sep; 55(9):1525-31. PubMed ID: 24970912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ⁶⁸Ga-NODAGA-VEGF₁₂₁ for in vivo imaging of VEGF receptor expression.
    Kang CM; Koo HJ; Choe YS; Choi JY; Lee KH; Kim BT
    Nucl Med Biol; 2014 Jan; 41(1):51-7. PubMed ID: 24183611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular imaging of changes in the prevalence of vascular endothelial growth factor receptor in sunitinib-treated murine mammary tumors.
    Levashova Z; Backer M; Hamby CV; Pizzonia J; Backer JM; Blankenberg FG
    J Nucl Med; 2010 Jun; 51(6):959-66. PubMed ID: 20484434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel.
    Hsu AR; Cai W; Veeravagu A; Mohamedali KA; Chen K; Kim S; Vogel H; Hou LC; Tse V; Rosenblum MG; Chen X
    J Nucl Med; 2007 Mar; 48(3):445-54. PubMed ID: 17332623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET of vascular endothelial growth factor receptor expression.
    Cai W; Chen K; Mohamedali KA; Cao Q; Gambhir SS; Rosenblum MG; Chen X
    J Nucl Med; 2006 Dec; 47(12):2048-56. PubMed ID: 17138749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of ligand density on in vivo tumor targeting of nanographene oxide.
    Lee JH; Sahu A; Jang C; Tae G
    J Control Release; 2015 Jul; 209():219-28. PubMed ID: 25937319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graphene oxide triggers toll-like receptors/autophagy responses in vitro and inhibits tumor growth in vivo.
    Chen GY; Chen CL; Tuan HY; Yuan PX; Li KC; Yang HJ; Hu YC
    Adv Healthc Mater; 2014 Sep; 3(9):1486-95. PubMed ID: 24652749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor vasculature targeting and imaging in living mice with reduced graphene oxide.
    Shi S; Yang K; Hong H; Valdovinos HF; Nayak TR; Zhang Y; Theuer CP; Barnhart TE; Liu Z; Cai W
    Biomaterials; 2013 Apr; 34(12):3002-9. PubMed ID: 23374706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DW10075, a novel selective and small-molecule inhibitor of VEGFR, exhibits antitumor activities both in vitro and in vivo.
    Li MY; Lv YC; Tong LJ; Peng T; Qu R; Zhang T; Sun YM; Chen Y; Wei LX; Geng MY; Duan WH; Xie H; Ding J
    Acta Pharmacol Sin; 2016 Mar; 37(3):398-407. PubMed ID: 26806300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synergistic effect of folate and RGD dual ligand of nanographene oxide on tumor targeting and photothermal therapy in vivo.
    Jang C; Lee JH; Sahu A; Tae G
    Nanoscale; 2015 Nov; 7(44):18584-94. PubMed ID: 26489965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graphene oxide-chloroquine nanoconjugate induce necroptotic death in A549 cancer cells through autophagy modulation.
    Arya BD; Mittal S; Joshi P; Pandey AK; Ramirez-Vick JE; Singh SP
    Nanomedicine (Lond); 2018 Sep; 13(18):2261-2282. PubMed ID: 30284495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A tumor-targeting near-infrared laser-triggered drug delivery system based on GO@Ag nanoparticles for chemo-photothermal therapy and X-ray imaging.
    Shi J; Wang L; Zhang J; Ma R; Gao J; Liu Y; Zhang C; Zhang Z
    Biomaterials; 2014 Jul; 35(22):5847-61. PubMed ID: 24746963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer.
    Wu Y; Zhong Z; Huber J; Bassi R; Finnerty B; Corcoran E; Li H; Navarro E; Balderes P; Jimenez X; Koo H; Mangalampalli VR; Ludwig DL; Tonra JR; Hicklin DJ
    Clin Cancer Res; 2006 Nov; 12(21):6573-84. PubMed ID: 17085673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxicity of Graphene Oxide (GO) and Graphene Oxide Conjugated Losartan Potassium (GO-LP) on Neuroblastoma (NB41A3) Cells.
    Kaur R; Verma S; Joshi P; Singh SP; Singh M
    J Nanosci Nanotechnol; 2018 Oct; 18(10):6765-6775. PubMed ID: 29954492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantum dots-bevacizumab complexes for in vivo imaging of tumors.
    Gazouli M; Bouziotis P; Lyberopoulou A; Ikonomopoulos J; Papalois A; Anagnou NP; Efstathopoulos EP
    In Vivo; 2014; 28(6):1091-5. PubMed ID: 25398804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ScVEGF-PEG-HBED-CC and scVEGF-PEG-NOTA conjugates: comparison of easy-to-label recombinant proteins for [68Ga]PET imaging of VEGF receptors in angiogenic vasculature.
    Eder M; Krivoshein AV; Backer M; Backer JM; Haberkorn U; Eisenhut M
    Nucl Med Biol; 2010 May; 37(4):405-12. PubMed ID: 20447550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.